OTC Test Market By Product and Technology - Global Industry Analysis & Forecast to 2027
Published On : April 2019 Pages : 180 Category: Medical Devices Report Code : HC043228
OTC Test Market By Product (Cholesterol Monitoring Test, Fecal Occult Test, Drug Abuse Test, Glucose Monitoring Test, Infectious Disease Testing, Urine Analysis Test) Technology (Lateral Flow Assay, Immunoassay) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The OTC Test Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Over the Counter Tests (OTC) are the ones that can be done without a doctor’s prescription. These tests are independent of clinics or healthcare settings and can be performed by users easily. Users self-select that the test is appropriate for symptoms or risk behaviors. These tests come with instructions that can be followed easily.
Drivers and Restraints
Main aspects, for example, developing awareness in regards to early determination of illness, commonness of irresistible ailments, and the requirement for minimal effort indicative testing combined with analysis precision are relied upon to support the development of the OTC tests market amid the gauge time frame. Moreover, development in customized care and increment in limited time exercises by makers empower the utilization of OTC tests, in this manner moving the development of the market.
Regional Insights
The Asia Pacific is evaluated to develop at the most noteworthy CAGR amid the figure time frame. The high development in this territorial portion is significantly ascribed to the expanding tolerant populace base and the developing pervasiveness of irresistible infections.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Roche Diagnostics
- Orasure Technologies
- LIA Diagnostics
- SD Biosensor
- Sinocare
- Abbott Laboratories
- Accubiotech
- Labstyle Innovations
- Acon Laboratories Inc
- Nowdiagnostics Company
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· OTC Test Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Cholesterol Monitoring Test
o Fecal Occult Test
o Drug Abuse Test
o Glucose Monitoring Test
o Infectious Disease Testing
o Urine Analysis Test
· OTC Test Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
o Lateral Flow Assay
o Immunoassay
· OTC Test Market, By Key Players
o Roche Diagnostics
o Orasure Technologies
o LIA Diagnostics
o SD Biosensor
o Sinocare
o Abbott Laboratories
o Accubiotech
o Labstyle Innovations
o Acon Laboratories Inc
o Nowdiagnostics Company
· OTC Test Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America OTC Test Market, By Country
o U.S. OTC Test Market
o Canada OTC Test Market
o Mexico OTC Test Market
o Europe
§ Europe OTC Test Market, By Country
o Germany OTC Test Market
o UK OTC Test Market
o France OTC Test Market
o Russia OTC Test Market
o Italy OTC Test Market
o Rest of Europe OTC Test Market
o Asia-Pacific
§ Asia-Pacific OTC Test Market, By Country
o China OTC Test Market
o Japan OTC Test Market
o South Korea OTC Test Market
o India OTC Test Market
o Southeast Asia OTC Test Market
o Rest of Asia-Pacific OTC Test Market
o South America
§ South America OTC Test Market
o Brazil OTC Test Market
o Argentina OTC Test Market
o Columbia OTC Test Market
o Rest of South America OTC Test Market
o Middle East and Africa
§ Middle East and Africa OTC Test Market
o Saudi Arabia OTC Test Market
o UAE OTC Test Market
o Egypt OTC Test Market
o Nigeria OTC Test Market
o South Africa OTC Test Market
o Rest of MEA OTC Test Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. OTC Test Market, By Product
5.1. Introduction
5.2. Global OTC Test Revenue and Market Share by Product (2017-2027)
5.2.1. Global OTC Test Revenue and Revenue Share by Product (2017-2027)
5.3. Cholesterol Monitoring Test
5.3.1. Global Cholesterol Monitoring Test Revenue and Growth Rate (2017-2027)
5.4. Fecal Occult Test
5.4.1. Global Fecal Occult Test Revenue and Growth Rate (2017-2027)
5.5. Drug Abuse Test
5.5.1. Global Drug Abuse Test Revenue and Growth Rate (2017-2027)
5.6. Glucose Monitoring Test
5.6.1. Global Glucose Monitoring Test Revenue and Growth Rate (2017-2027)
5.7. Infectious Disease Testing
5.7.1. Global Infectious Disease Testing Revenue and Growth Rate (2017-2027)
5.8. Urine Analysis Test
5.8.1. Global Urine Analysis Test Revenue and Growth Rate (2017-2027)
6. OTC Test Market, By Technology
6.1. Introduction
6.2. Global OTC Test Revenue and Market Share by Technology (2017-2027)
6.2.1. Global OTC Test Revenue and Revenue Share by Technology (2017-2027)
6.3. Lateral Flow Assay
6.3.1. Global Lateral Flow Assay Revenue and Growth Rate (2017-2027)
6.4. Immunoassay
6.4.1. Global Immunoassay Revenue and Growth Rate (2017-2027)
7. OTC Test Market, By Region
7.1. Introduction
7.2. Global OTC Test Revenue and Market Share by Regions
7.2.1. Global OTC Test Revenue by Regions (2017-2027)
7.3. North America OTC Test by Countries
7.3.1. North America OTC Test Revenue and Growth Rate (2017-2027)
7.3.2. North America OTC Test Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe OTC Test by Countries
7.4.1. Europe OTC Test Revenue and Growth Rate (2017-2027)
7.4.2. Europe OTC Test Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific OTC Test by Countries
7.5.1. Asia-Pacific OTC Test Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific OTC Test Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America OTC Test by Countries
7.6.1. South America OTC Test Revenue and Growth Rate (2017-2027)
7.6.2. South America OTC Test Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa OTC Test by Countries
7.7.1. Middle East and Africa OTC Test Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa OTC Test Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Roche Diagnostics
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Orasure Technologies
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. LIA Diagnostics
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. SD Biosensor
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Sinocare
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Abbott Laboratories
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Accubiotech
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Labstyle Innovations
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Acon Laboratories Inc
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Nowdiagnostics Company
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Global OTC Test Market Competition, by Manufacturer
9.1. Global OTC Test Financial Overview by Manufacturer (2017-2017)
9.2. Global OTC Test Price By Region (2017-2017)
9.3. Top 5 OTC Test Manufacturer Market Share
9.4. Market Competition Trend
10. OTC Test Market Forecast (2017-2027)
10.1. Global OTC Test Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. OTC Test Market Forecast by Regions (2017-2027)
10.2.1. North America OTC Test Market Forecast (2017-2027)
10.2.1.1. United States OTC Test Market Forecast (2017-2027)
10.2.1.2. Canada OTC Test Market Forecast (2017-2027)
10.2.1.3. Mexico OTC Test Market Forecast (2017-2027)
10.2.2. Europe OTC Test Market Forecast (2017-2027)
10.2.2.1. Germany OTC Test Market Forecast (2017-2027)
10.2.2.2. France OTC Test Market Forecast (2017-2027)
10.2.2.3. UK OTC Test Market Forecast (2017-2027)
10.2.2.4. Russia OTC Test Market Forecast (2017-2027)
10.2.2.5. Italy OTC Test Market Forecast (2017-2027)
10.2.2.6. Rest of Europe OTC Test Market Forecast (2017-2027)
10.2.3. Asia-Pacific OTC Test Market Forecast (2017-2027)
10.2.3.1. China OTC Test Market Forecast (2017-2027)
10.2.3.2. Japan OTC Test Market Forecast (2017-2027)
10.2.3.3. Korea OTC Test Market Forecast (2017-2027)
10.2.3.4. India OTC Test Market Forecast (2017-2027)
10.2.3.5. Southeast Asia OTC Test Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific OTC Test Market Forecast (2017-2027)
10.2.4. South America OTC Test Market Forecast (2017-2027)
10.2.4.1. Brazil OTC Test Market Forecast (2017-2027)
10.2.4.2. Argentina OTC Test Market Forecast (2017-2027)
10.2.4.3. Columbia OTC Test Market Forecast (2017-2027)
10.2.4.4. Rest of South America OTC Test Market Forecast (2017-2027)
10.2.5. Middle East and Africa OTC Test Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia OTC Test Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates OTC Test Market Forecast (2017-2027)
10.2.5.3. Egypt OTC Test Market Forecast (2017-2027)
10.2.5.4. Nigeria OTC Test Market Forecast (2017-2027)
10.2.5.5. South Africa OTC Test Market Forecast (2017-2027)
10.2.5.6. Turkey OTC Test Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa OTC Test Market Forecast (2017-2027)
10.3. OTC Test Market Forecast by Product (2017-2027)
10.3.1. OTC Test Forecast by Product (2017-2027)
10.3.2. OTC Test Market Share Forecast by Product (2017-2027)
10.4. OTC Test Market Forecast by Technology (2017-2027)
10.4.1. OTC Test Forecast by Technology (2017-2027)
10.4.2. OTC Test Market Share Forecast by Technology (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure France OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure China OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure India OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa OTC Test Revenue (Million USD) and Growth Rate (2017-2025)
Table Global OTC Test Revenue and Revenue Share by Product (2017-2018)
Figure Global Cholesterol Monitoring Test Revenue and Growth Rate (2017-2018)
Figure Global Fecal Occult Test Revenue and Growth Rate (2017-2018)
Figure Global Drug Abuse Test Revenue and Growth Rate (2017-2018)
Figure Global Glucose Monitoring Test Revenue and Growth Rate (2017-2018)
Figure Global Infectious Disease Testing Revenue and Growth Rate (2017-2018)
Figure Global Urine Analysis Test Revenue and Growth Rate (2017-2018)
Table Global OTC Test Revenue and Revenue Share by Technology (2017-2018)
Figure Global Lateral Flow Assay Revenue and Growth Rate (2017-2018)
Figure Global Immunoassay Revenue and Growth Rate (2017-2018)
Table Global OTC Test Revenue by Regions (2017-2018)
Figure North America OTC Test Growth Rate (2017-2018)
Figure North America OTC Test Revenue and Growth Rate (2017-2018)
Figure North America OTC Test by Countries (2017-2018)
Figure North America OTC Test Revenue (Million USD) by Countries (2017-2018)
Figure United States OTC Test Growth Rate (2017-2018)
Figure United States OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada OTC Test Growth Rate (2017-2018)
Figure Canada OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico OTC Test Growth Rate (2017-2018)
Figure Mexico OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe OTC Test Growth Rate (2017-2018)
Figure Europe OTC Test Revenue and Growth Rate (2017-2018)
Figure Europe OTC Test by Countries (2017-2018)
Figure Europe OTC Test Revenue (Million USD) by Countries (2017-2018)
Figure Germany OTC Test Growth Rate (2017-2018)
Figure Germany OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France OTC Test Growth Rate (2017-2018)
Figure France OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK OTC Test Growth Rate (2017-2018)
Figure UK OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia OTC Test Growth Rate (2017-2018)
Figure Russia OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy OTC Test Growth Rate (2017-2018)
Figure Italy OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe OTC Test Growth Rate (2017-2018)
Figure Rest of Europe OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific OTC Test Growth Rate (2017-2018)
Figure Asia-Pacific OTC Test Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific OTC Test by Countries (2017-2018)
Figure Asia-Pacific OTC Test Revenue (Million USD) by Countries (2017-2018)
Figure China OTC Test Growth Rate (2017-2018)
Figure China OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan OTC Test Growth Rate (2017-2018)
Figure Japan OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea OTC Test Growth Rate (2017-2018)
Figure Korea OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India OTC Test Growth Rate (2017-2018)
Figure India OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia OTC Test Growth Rate (2017-2018)
Figure Southeast Asia OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific OTC Test Growth Rate (2017-2018)
Figure Rest of Asia-Pacific OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America OTC Test Growth Rate (2017-2018)
Figure South America OTC Test Revenue and Growth Rate (2017-2018)
Figure South America OTC Test by Countries (2017-2018)
Figure South America OTC Test Revenue (Million USD) by Countries (2017-2018)
Figure Brazil OTC Test Growth Rate (2017-2018)
Figure Brazil OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina OTC Test Growth Rate (2017-2018)
Figure Argentina OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia OTC Test Growth Rate (2017-2018)
Figure Columbia OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America OTC Test Growth Rate (2017-2018)
Figure Rest of South America OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa OTC Test Growth Rate (2017-2018)
Figure Middle East and Africa OTC Test Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa OTC Test by Countries (2017-2018)
Figure Middle East and Africa OTC Test Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia OTC Test Growth Rate (2017-2018)
Figure Saudi Arabia OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates OTC Test Growth Rate (2017-2018)
Figure United Arab Emirates OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt OTC Test Growth Rate (2017-2018)
Figure Egypt OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria OTC Test Growth Rate (2017-2018)
Figure Nigeria OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa OTC Test Growth Rate (2017-2018)
Figure South Africa OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey OTC Test Growth Rate (2017-2018)
Figure Turkey OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa OTC Test Growth Rate (2017-2018)
Figure Rest of Middle East and Africa OTC Test Revenue (Millions USD) and Growth Rate (2017-2018)
Table Roche Diagnostics OTC Test Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Orasure Technologies OTC Test Price, Revenue, Gross Margin and Market Share (2017-2017)
Table LIA Diagnostics OTC Test Price, Revenue, Gross Margin and Market Share (2017-2017)
Table SD Biosensor OTC Test Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sinocare OTC Test Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Laboratories OTC Test Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Accubiotech OTC Test Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Labstyle Innovations OTC Test Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Acon Laboratories Inc OTC Test Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Nowdiagnostics Company OTC Test Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global OTC Test Market Share by Manufacturer
Figure Global OTC Test Revenue and Market Share by Manufacturer
Table Global OTC Test Price by Region (2017-2017)
Figure Top 5 OTC Test Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global OTC Test Revenue (Millions USD) and Growth Rate (2018-2025)
Table OTC Test Market Forecast by Regions (2018-2025)
Figure North America OTC Test Market Forecast (2018-2025)
Figure United States OTC Test Market Forecast (2018-2025)
Figure Canada OTC Test Market Forecast (2018-2025)
Figure Mexico OTC Test Market Forecast (2018-2025)
Figure Europe OTC Test Market Forecast (2018-2025)
Figure Germany OTC Test Market Forecast (2018-2025)
Figure France OTC Test Market Forecast (2018-2025)
Figure UK OTC Test Market Forecast (2018-2025)
Figure Russia OTC Test Market Forecast (2018-2025)
Figure Italy OTC Test Market Forecast (2018-2025)
Figure Rest of Europe OTC Test Market Forecast (2018-2025)
Figure Asia-Pacific OTC Test Market Forecast (2018-2025)
Figure China OTC Test Market Forecast (2018-2025)
Figure Japan OTC Test Market Forecast (2018-2025)
Figure Korea OTC Test Market Forecast (2018-2025)
Figure India OTC Test Market Forecast (2018-2025)
Figure Southeast Asia OTC Test Market Forecast (2018-2025)
Figure Rest of Asia-Pacific OTC Test Market Forecast (2018-2025)
Figure South America OTC Test Market Forecast (2018-2025)
Figure Brazil OTC Test Market Forecast (2018-2025)
Figure Argentina OTC Test Market Forecast (2018-2025)
Figure Columbia OTC Test Market Forecast (2018-2025)
Figure Rest of South America OTC Test Market Forecast (2018-2025)
Figure Middle East and Africa OTC Test Market Forecast (2018-2025)
Figure Saudi Arabia OTC Test Market Forecast (2018-2025)
Figure United Arab Emirates OTC Test Market Forecast (2018-2025)
Figure Egypt OTC Test Market Forecast (2018-2025)
Figure Nigeria OTC Test Market Forecast (2018-2025)
Figure South Africa OTC Test Market Forecast (2018-2025)
Figure Turkey OTC Test Market Forecast (2018-2025)
Figure Rest of Middle East and Africa OTC Test Market Forecast (2018-2025)
Figure Global OTC Test Forecast by Product (2018-2025)
Figure Global OTC Test Market Share Forecast by Product (2018-2025)
Figure Global OTC Test Forecast by Product (2018-2025)
Figure Global OTC Test Forecast by Technology (2018-2025)
Figure Global OTC Test Market Share Forecast by Technology (2018-2025)
Figure Global OTC Test Forecast by Technology (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|